The Maine Event

“I think [November’s] going to be a watershed moment for legalisation in general,” said Rob Hunt, director at Teewinot Life Sciences. Hunt’s resume boasts stints as an attorney, consultant, and entrepreneur in the cannabis industry. Like many others who work in America’s sort-of-legal cannabis industry, he sees the coming election as a tipping point for … Continued

CBD Update: MHRA Delays Deadline for Manufacturer Compliance Until End of Year

Manufacturers of CBD products were rocked last month by the announcement that the Medicines and Healthcare products Regulatory Agency had taken the the decision to classify products containing CBD as Medicines. While generally regarded as a positive move long-term, the decision to give manufacturers and retailers only 28 days to voluntarily comply had been met with … Continued

Zero Zero Zero

Zero Zero Zero – Roberto Saviano (London: Penguin Books, 2016) Roberto Saviano, an Italian investigative journalist, is most famous for his pioneering work Gomorrah, about the Italian organised crime group the Camorra. He now lives in hiding, a police guard always by his side, testament to the danger of speaking out about organised crime. His latest … Continued

High-CBD Cannabis Now Sold Legally in Switzerland (as a ‘Tobacco Substitute’)

This article was originally published on Leafly. An organic gardening company in Switzerland has managed to make high-CBD cannabis flower available to consumers by capping the THC content and registering the product with regulators as a tobacco substitute. The Fedora strain, cultivated by northern Swiss grower Bio Can, is advertised at 7.2 percent CBD and just … Continued

MRHA Ruling: The CBD Industry Speaks Out

Manufacturers and distributors of cannabidiol (CBD) based products have spoken out after the Medicine products Regulatory Agency (MHRA) told vendors they have 28 days to stop selling their products in the UK. The decision was made by the MHRA to define CBD as a medicine, meaning that companies will now require a licence to sell … Continued

The Global Medical Cannabis Summit: History in the Making

The Global Medical Cannabis Summit: Advancements in the Age of Cannabis (Dublin, 2016) On 14th September at the Smock Alley Theatre in Dublin, international experts from science, policy, campaigning and business backgrounds were brought together to explore emerging new innovations in medical cannabis. Hosted by VolteFace and Help not Harm, and sponsored by Tilray and … Continued

Priming The Pot

Next week the All Party Parliamentary Group for drug reform will publish a report on medical access to cannabis. On the eve of the report we invited award winning journalist and David Cameron’s former speechwriter to the US to meet the most influential legal supplier in the country. He provides compelling insights into the future trajectory … Continued

Medical Cannabis Giant Could Be Bought Out

British medical cannabis provider GW Pharmaceuticals could be about to be taken over by an unidentified investor, as they discuss options with investment bank Morgan Stanley. Shares in the company that developed Epidiolex, a cannabis-based treatment for epilepsy, have shot up by 22% since news of this consultation spread. Epidiolex is currently in late-stage clinical … Continued